Financhill
Back

ANI Pharmaceuticals Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
24

ANIP
ANI Pharmaceuticals

Last Price:
$54.03
Seasonality Move:
6.61%
Buy
61

ITCI
Intra-Cellular Therapies

Last Price:
$127.20
Seasonality Move:
2.9%
Sell
24
ANI Pharmaceuticals (ANIP) is a Sell

Is ANI Pharmaceuticals a Buy, Sell or Hold?

  • The current ANI Pharmaceuticals [ANIP] share price is $53.93. The Score for ANIP is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • ANIP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Intra-Cellular Therapies (ITCI) is a Buy

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $127.19. The Score for ITCI is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • ITCI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ANIP Stock Price Chart

What is ANI Pharmaceuticals's stock price today?

  • The ANI Pharmaceuticals share price today is $53.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANIP is experiencing slight buying pressure.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $127.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight selling pressure.

ANIP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.66 Sell
Relative Strength Index (14 RSI): 42.17 Sell
Chaikin Money Flow: 30282 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.93 - 57.03) Sell
Bollinger Bands (100): (55.46 - 60.54) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.82 Buy
Relative Strength Index (14 RSI): 87.68 Buy
Chaikin Money Flow: -16907827 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (77.65 - 95.01) Buy
Bollinger Bands (100): (72.96 - 88.08) Buy

ANIP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.79 Sell
20-day SMA: 54.88 Sell
50-day SMA: 56.69 Sell
200-day SMA: 61.01 Sell
8-day EMA: 54.58 Sell
20-day EMA: 55.13 Sell
50-day EMA: 56.35 Sell
200-day EMA: 58.63 Sell

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 90.14 Buy
20-day SMA: 86.88 Buy
50-day SMA: 86.49 Buy
200-day SMA: 76.02 Buy
8-day EMA: 95.08 Buy
20-day EMA: 89.04 Buy
50-day EMA: 85.45 Buy
200-day EMA: 77.14 Buy

ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $1.04 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $3.25 per share.

ANI Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):